Endogenous Depression Affects 7% of U.S. Adults Annually
Endogenous depression, a severe form of major depressive disorder (MDD), affects nearly 7% of adults in the United States annually. Unlike MDD triggered by stressful events, endogenous depression appears suddenly and without apparent cause. It's characterized by persistent sadness, loss of interest, and physical symptoms, lasting more than two weeks. Diagnosis involves meeting specific criteria from the Diagnostic and Statistical Manual of Mental Disorders (DSM).
Symptoms of endogenous depression include persistent sadness, fatigue, lack of motivation, trouble concentrating, sleep disturbances, social isolation, and physical aches. Thoughts of suicide may also occur. Treatment often combines medication and therapy. Medications include selective serotonin reuptake inhibitors (SSRIs), selective serotonin and norepinephrine reuptake inhibitors (SNRIs), and tricyclic antidepressants (TCAs). Psychotherapy, such as cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT), helps individuals cope with their condition. For severe cases, electroconvulsive therapy (ECT) or other interventions like repetitive transcranial magnetic stimulation (rTMS) and light therapy may be used. Lifestyle changes, like regular exercise, social interaction, and a healthy diet, can also aid in managing symptoms.
Endogenous depression, a serious mental health condition, requires professional help. Treatment typically involves a combination of medication and therapy, with additional interventions for severe cases. Lifestyle changes can also play a role in managing symptoms. Nearly 7% of adults in the U.S. experience this condition each year, highlighting the need for awareness, understanding, and effective treatment.
